Kumar R, Hughes D C, Roberts E F. "一种左氯替西汀酰胺杂质19的合成方法" [P]. US Patent, US 11640190 B2, 2015-07-10.
发明人张德明,冯建国,郭海燕. "Method for the Synthesis of Levocetirizine Impurity 19" [P]. 中国发明专利, 专利号 CN 117716038 B, 授权公告日 2024-08-16.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 左氯替西汀酰胺杂质19 in Pharmaceutical Formulations". Chemosphere, 2011, 1808, (10), 9561-9576.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左氯替西汀酰胺杂质19 as an Impurity". J. Nat. Prod., 2010, 108, (9), 6419-6429.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Levocetirizine Impurity 19 Using HRMS and NMR". Biomed. Chromatogr., 2013, 292, 7776-7804.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 左氯替西汀酰胺杂质19 Profile in Drug Substances According to ICH Guidelines". Talanta, 2023, 1521, (2), 130-139.